U.S. News & World Report: Wegovy Helps Heart Failure Patients Lose Weight, Improve Symptoms

 1 minute

Weight-loss drugs like Wegovy can improve symptoms in heart failure patients, a new clinical trial shows.

Both men and women showed improved heart function after a year on semaglutide, the active ingredient in Ozempic and Wegovy, researchers report.

Women tended to lose more weight than men, on average about 9.6% of their body weight compared with 7.2% in men.

However, both genders experienced similar improvements regarding their heart health, researchers found. This could mean the drug might have heart benefits above and beyond helping people lose weight.

The results shed light on “the consistent benefits of semaglutide for women and men,” said senior researcher Dr. Mikhail Kosiborod, a cardiologist and vice president of research at Saint Luke's Mid America Heart Institute in Kansas City, Mo.

Read the full U.S. News & World Report article: Wegovy Helps Heart Failure Patients Lose Weight, Improve Symptoms